Stock listing

8NE Stock Price, News, Filings & Events — Lisata Therapeutics, Inc.

Selected listing: 8NE · TRADEGATE · EUR · DE

The 8NE:TRADEGATE listing represents Lisata Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company is actively engaged in advancing its clinical programs and has been involved in recent news regarding its research and development efforts. Investors can find updates on regulatory filings and upcoming events that may impact the company's market position. As the biotechnology sector evolves, Lisata Therapeutics continues to navigate the landscape with its commitment to addressing unmet medical needs.

8NE:TRADEGATEEURDEUpdated July 24, 2026
Lisata Therapeutics, Inc. logo
Ticker
8NE:TRADEGATE
Asset type
Stock
Market cap
$15.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
TRADEGATE
Currency
EUR

Lisata Therapeutics, Inc. 8NE:TRADEGATE stock context

The 8NE:TRADEGATE listing represents Lisata Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for cancer and other serious diseases. The company is actively engaged in advancing its clinical programs and has been involved in recent news regarding its research and development efforts. Investors can find updates on regulatory filings and upcoming events that may impact the company's market position. As the biotechnology sector evolves, Lisata Therapeutics continues to navigate the landscape with its commitment to addressing unmet medical needs.

Research Lisata Therapeutics, Inc.

Alternate listings